<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="48529">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01832428</url>
  </required_header>
  <id_info>
    <org_study_id>00107</org_study_id>
    <nct_id>NCT01832428</nct_id>
  </id_info>
  <brief_title>A Clinical Trial to Study the Safety and Efficacy of Bone Marrow Derived Autologous Cell for the Treatment of Stroke.</brief_title>
  <acronym>BMACS</acronym>
  <official_title>A Clinical Trial to Study the Safety and Efficacy of Bone Marrow Derived Autologous Cell for the Treatment of Stroke.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chaitanya Hospital, Pune</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chaitanya Hospital, Pune</source>
  <oversight_info>
    <authority>India: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is single,  centre trial to study the safety and efficacy of Bone marrow derived
      autologous MNCS(100 million per dose)trial to be conducted for 36 months in stroke patients
      , the primary outcome measure will be the improvement in muscle power of Body and face
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is single centre trial to study  the safety and efficacy of Bone marrow derived
      autologous MNCS(100 million per dose)trial to be conducted for 36 months in stroke patients
      , the primary outcome measure will be the improvement in muscle power of Body and face
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Anticipated">March 2014</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Improvement in power of Body and facial Muscles</measure>
    <time_frame>6 Months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Improvement in power of Body and facial Muscles.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement in Walking Ability</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Improvement in Walking Ability in 6 month.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement In Speech and cognition</measure>
    <time_frame>6 Months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>- Improvement In Speech and cognition ,Time period-6 month</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement in Vision in both eyes</measure>
    <time_frame>6 month</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Improvement in Vision in both eyes 6 month</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Stroke,</condition>
  <arm_group>
    <arm_group_label>Transfer of autologous MNC intrathecally</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Intra thecal transplantation of autologous stem cells 100 Millions per dose in 3 divided doses at interval of  7days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Intra thecal transplantation of Autologous Stem Cells</intervention_name>
    <description>Intra thecal transplantation of Autologous Stem Cells</description>
    <arm_group_label>Transfer of autologous MNC intrathecally</arm_group_label>
    <other_name>Intra thecal transplantation of Autologous Stem Cells</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient should suffer from stroke due to cerebral infarct or Haemorrhage or
             accelerated hypertension.

          -  willingness to undergo bone marrow derived autologous cell therapy.

          -  patient those provide fully Informed consent form for the study.

          -  Ability and willingness to regular visit to hospital and follow up during the
             protocol Procedure.

        Exclusion Criteria:

          -  Patients with pre - existing or Current systemic disease such as lung , liver (
             exception; History of uncomplicated Hepatitis A),gastrointestinal, Cardiac ,
             Immunodeficiency,(including HIV) Or laboratory Investigation that could cause a
             neurological defect.History of Life threating Allergic or immune- mediated reaction.

          -  Alcohol and drug abuse / dependence.

          -  Severe skin infection.

          -  Haemodynamically unstable.

          -  subject with primary and secondary diabetes , Insulin depenence,
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ANANT E BAGUL, M.S</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHAITANYA HOSPITAL</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sachin P Jamadar, Dortho</last_name>
    <phone>+918888788880</phone>
    <email>sac2751982@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Smita S Bhoyar, B.A.M.S.PGCR</last_name>
    <phone>9372620569</phone>
    <email>drsmitabhoyar@rediff.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chaitanya Hospital</name>
      <address>
        <city>Pune</city>
        <state>Maharashtra</state>
        <zip>411009</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sachin P Jamadar, Dortho</last_name>
      <phone>+918888788880</phone>
      <email>sac2751982@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Smita S Bhoyar, BAMS PGCR</last_name>
      <phone>+9372620569</phone>
      <email>drsmitabhoyar@rediffmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>ANANT E BAGUL, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>April 12, 2013</lastchanged_date>
  <firstreceived_date>April 9, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chaitanya Hospital, Pune</investigator_affiliation>
    <investigator_full_name>Dr. Sachin Jamadar</investigator_full_name>
    <investigator_title>CO-Investigator</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
